From UW Synthetic Biology to Global Scale: Parse Biosciences’ $225M Acquisition
QIAGEN’s planned $225M cash acquisition of Parse Biosciences, announced in November 2025, marked a major milestone for a company built directly on research from the…
2025 Engineering Biology Research Consortium
Our 2025 Annual Meeting will be held May 1-2, 2025 at the University of Washington in Seattle, WA! The EBRC Annual Meeting provides an opportunity for…
Retooling microbes to upcycle CO2
The U.S. Department of Energy has awarded a 5-year, $15 million grant to an interdisciplinary, UW-led team of synthetic biologists to engineer microbial genomes that…
Unlocking biotechnology with RNA
Two recent molecular engineering graduates launched a new startup, Wayfinder Biosciences, to commercialize their revolutionary platform to design RNA molecules that can be used to…
UW BIOFAB: A force for reproducible science
The UW’s Biofabrication Center, a unique facility dedicated to enabling the rapid design, construction and testing of genetically reprogrammed organisms, is partnering with Agilent Technologies…